2009
DOI: 10.1038/ng.439
|View full text |Cite
|
Sign up to set email alerts
|

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

Abstract: The gene encoding apolipoprotein E (APOE) on chromosome 19 is the only confirmed susceptibility locus for late-onset Alzheimer's disease. To identify other risk loci, we conducted a large genome-wide association study of 2,032 individuals from France with Alzheimer's disease (cases) and 5,328 controls. Markers outside APOE with suggestive evidence of association (P < 10(-5)) were examined in collections from Belgium, Finland, Italy and Spain totaling 3,978 Alzheimer's disease cases and 3,297 controls. Two loci… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

50
1,752
8
9

Year Published

2010
2010
2018
2018

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 2,081 publications
(1,823 citation statements)
references
References 77 publications
(49 reference statements)
50
1,752
8
9
Order By: Relevance
“…Carbonyl reductase is elevated in hippocampi of 3xTg‐AD mice, which have markedly elevated levels of protein carbonylation (Shen et al ., 2015). Clusterin (ApoJ) polymorphism is associated with AD (Lambert et al ., 2009), and its circulating levels predict AD progression (Thambisetty et al ., 2010). Other apolipoproteins are also strongly linked to AD risk: ApoD catalyzes reduction of peroxidized lipids and its levels increase with age and AD, while ApoE has allele‐specific effects on Aβ levels and AD risk (Tai et al ., 2013; Dassati et al ., 2014).…”
Section: Discussionmentioning
confidence: 99%
“…Carbonyl reductase is elevated in hippocampi of 3xTg‐AD mice, which have markedly elevated levels of protein carbonylation (Shen et al ., 2015). Clusterin (ApoJ) polymorphism is associated with AD (Lambert et al ., 2009), and its circulating levels predict AD progression (Thambisetty et al ., 2010). Other apolipoproteins are also strongly linked to AD risk: ApoD catalyzes reduction of peroxidized lipids and its levels increase with age and AD, while ApoE has allele‐specific effects on Aβ levels and AD risk (Tai et al ., 2013; Dassati et al ., 2014).…”
Section: Discussionmentioning
confidence: 99%
“…The effect sizes of these genetic associations were much smaller than for APOE ,2, 6 with odds ratios ranging from 1.16 to 1.20. Follow‐up GWAS identified additional LOAD susceptibility variants 7, 8.…”
mentioning
confidence: 80%
“…The first large‐scale genome‐wide association studies (GWAS) using common single nucleotide polymorphisms (SNPs) identified CLU , PICALM , CR1, and BIN1 as late onset Alzheimer disease (LOAD) susceptibility loci,1, 2, 3 which were widely confirmed by others 4, 5. The effect sizes of these genetic associations were much smaller than for APOE ,2, 6 with odds ratios ranging from 1.16 to 1.20.…”
mentioning
confidence: 99%
“…We also included known early‐onset AD genes and genes implicated in earlier sequencing efforts in LOAD 1, 2, 3, 4, 5, 6, 8, 9, 10, 11, 12, 13, 14, 15, 16. Candidate genes evaluated included: APP, PSEN1, PSEN2, GRN, MAPT, TREM2, PLD3, APOE, ABCA7, SORL1, CR1, BIN1, CD2AP, EPHA1, CLU, MS4A6A, PICALM, CD33, HLA‐DRB5, HLA‐DRB1, PTK2B, SLC24A4, RIN3, INPP5D, MEF2C, NME8, ZCWPW1, CELF1, FERMT2, CASS4, TREML2, and AKAP9 .…”
Section: Methodsmentioning
confidence: 99%
“…Several genes within LOAD susceptibility loci cluster in specific pathways,1, 2, 3, 4, 5, 6 including amyloid processing, oxidative stress and immune or inflammatory pathways. Collectively, GWAS demonstrates that apart from the strongest risk factor, APOE‐ε4 a large number of loci with modest effect size also contribute to LOAD risk.…”
Section: Introductionmentioning
confidence: 99%